ANI PHARMACEUTICALS INC(NASDAQ:ANIP) stock News

ANIP Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Chartmill

ANI Pharmaceuticals Inc (NASDAQ:ANIP) Screens as High Growth Momentum Stock Meeting Minervini Trend Template

9 days ago - By: Chartmill

ANI Pharmaceuticals Inc (NASDAQ:ANIP) Combines Strong Growth Momentum with Bullish Technical Setup

2 days ago - By: Zacks Investment Research - Mentions: ALGN IDXX EXAS

ALGN Gears Up for Q3 Earnings: What Lies Ahead for the Stock?

2 days ago - By: Zacks Investment Research - Mentions: IDXX EXAS EHC

Here's How IDEXX Laboratories is Placed Ahead of Q3 Earnings

5 days ago - By: Zacks Investment Research - Mentions: ESPR EVO CMMB

ESPR Aims to Diversify With Rare Liver Disease Candidate, Stock Up

6 days ago - By: ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals Announces NEW DAY Clinical Trial Results to be Presented in Late-Breaking Oral Presentation at the American Academy of Ophthalmology 2025 Meeting

12 days ago - By: Zacks Investment Research

3 Reasons Why Growth Investors Shouldn't Overlook ANI (ANIP)

23 days ago - By: Zacks Investment Research - Mentions: HALO ABBV ARGX

AbbVie Seeks FDA Nod for Tavapadon to Treat Parkinson's Disease

a month ago - By: Benzinga

6 Analysts Have This To Say About ANI Pharmaceuticals

a month ago - By: Zacks Investment Research - Mentions: NVS INCY CRMD

INCY Announces New Late-Stage Data on Skin Disease Drug

a month ago - By: Zacks Investment Research - Mentions: PBYI CRMD

PBYI Surges 30% in 3 Months: How Should You Play the Stock?

a month ago - By: Zacks Investment Research

3 Reasons Why Growth Investors Shouldn't Overlook ANI (ANIP)

a month ago - By: Zacks Investment Research - Mentions: ADAG

Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?

a month ago - By: Zacks Investment Research

ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue?

a month ago - By: Benzinga

4 Analysts Have This To Say About ANI Pharmaceuticals

2 months ago - By: Zacks Investment Research - Mentions: BIIB LLY CRMD

Biogen Secures FDA Nod for Subcutaneous Maintenance Dosing of Leqembi

2 months ago - By: Zacks Investment Research - Mentions: JNJ CRMD

J&J Ends Imaavy Development in Rheumatoid Arthritis Post Study Failure

2 months ago - By: Zacks Investment Research - Mentions: ADPT

Adaptive Biotechnologies Corporation (ADPT) Hits Fresh High: Is There Still Room to Run?

2 months ago - By: Zacks Investment Research

ANI Pharmaceuticals (ANIP) is a Great Momentum Stock: Should You Buy?

2 months ago - By: Zacks Investment Research - Mentions: MRK CRMD IOVA

IOVA Stock Drops 6% on $350M Common Stock Offering

2 months ago - By: ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals to Present at Upcoming Investor Conferences

2 months ago - By: Zacks Investment Research

Is ANI (ANIP) a Solid Growth Stock? 3 Reasons to Think "Yes"

2 months ago - By: Zacks Investment Research - Mentions: GILD CVS CRMD

GILD Stock Slips as CVS Health Excludes New HIV Drug Yeztugo

2 months ago - By: Zacks Investment Research - Mentions: AMRN

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?

2 months ago - By: Zacks Investment Research

ANI Pharmaceuticals, Inc. (ANIP) Hits Fresh High: Is There Still Room to Run?

2 months ago - By: Zacks Investment Research

ANI PHARMACEUTICALS INC (ANIP) Stock News

ANIP Latest News, Press Relases and Analysis

ANI Pharmaceuticals Inc (NASDAQ:ANIP) Screens as High Growth Momentum Stock Meeting Minervini Trend Template

ANI Pharmaceuticals Inc (NASDAQ:ANIP) Combines Strong Growth Momentum with Bullish Technical Setup

ALGN Gears Up for Q3 Earnings: What Lies Ahead for the Stock?

Here's How IDEXX Laboratories is Placed Ahead of Q3 Earnings

ESPR Aims to Diversify With Rare Liver Disease Candidate, Stock Up

ANI Pharmaceuticals Announces NEW DAY Clinical Trial Results to be Presented in Late-Breaking Oral Presentation at the American Academy of Ophthalmology 2025 Meeting

3 Reasons Why Growth Investors Shouldn't Overlook ANI (ANIP)

AbbVie Seeks FDA Nod for Tavapadon to Treat Parkinson's Disease

6 Analysts Have This To Say About ANI Pharmaceuticals

INCY Announces New Late-Stage Data on Skin Disease Drug

PBYI Surges 30% in 3 Months: How Should You Play the Stock?

3 Reasons Why Growth Investors Shouldn't Overlook ANI (ANIP)

Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?

ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue?

4 Analysts Have This To Say About ANI Pharmaceuticals

Biogen Secures FDA Nod for Subcutaneous Maintenance Dosing of Leqembi

J&J Ends Imaavy Development in Rheumatoid Arthritis Post Study Failure

Adaptive Biotechnologies Corporation (ADPT) Hits Fresh High: Is There Still Room to Run?

ANI Pharmaceuticals (ANIP) is a Great Momentum Stock: Should You Buy?

IOVA Stock Drops 6% on $350M Common Stock Offering

ANI Pharmaceuticals to Present at Upcoming Investor Conferences

Is ANI (ANIP) a Solid Growth Stock? 3 Reasons to Think "Yes"

GILD Stock Slips as CVS Health Excludes New HIV Drug Yeztugo

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?

ANI Pharmaceuticals, Inc. (ANIP) Hits Fresh High: Is There Still Room to Run?

ANI (ANIP) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates